Unicycive Therapeutics

UNCYNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$138.883 M

$5.07 +0.40%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$26.6M

Loss-making

Shares outstanding

25,237,782

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#287Organigram GlobalOGI$139.4M
#288vTv TherapeuticsVTVT$139.3M
#289Unicycive TherapeuticsUNCY$138.9M
#290Connect BiopharmaCNTB$138.8M
#291TuHURA BiosciencesHURA$135.6M

Where these numbers come from

Share counts and financials for Unicycive Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.